Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.

Labelle M, Begum S, Hynes RO.

Cancer Cell. 2011 Nov 15;20(5):576-90. doi: 10.1016/j.ccr.2011.09.009.

2.

Platelet P2Y12 is involved in murine pulmonary metastasis.

Wang Y, Sun Y, Li D, Zhang L, Wang K, Zuo Y, Gartner TK, Liu J.

PLoS One. 2013 Nov 13;8(11):e80780. doi: 10.1371/journal.pone.0080780. eCollection 2013.

3.

HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment.

Cedervall J, Zhang Y, Ringvall M, Thulin A, Moustakas A, Jahnen-Dechent W, Siegbahn A, Olsson AK.

Angiogenesis. 2013 Oct;16(4):889-902. doi: 10.1007/s10456-013-9363-8. Epub 2013 Jun 22.

PMID:
23793459
4.
5.

NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells.

Kumar M, Allison DF, Baranova NN, Wamsley JJ, Katz AJ, Bekiranov S, Jones DR, Mayo MW.

PLoS One. 2013 Jul 30;8(7):e68597. doi: 10.1371/journal.pone.0068597. Print 2013.

6.

Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.

Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.

Carcinogenesis. 2013 Apr;34(4):874-84. doi: 10.1093/carcin/bgs396. Epub 2012 Dec 28.

PMID:
23275155
7.

Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.

Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q.

BMC Cancer. 2015 Mar 5;15:97. doi: 10.1186/s12885-015-1119-y.

8.

Direct TGF-β1 signaling between activated platelets and pancreatic cancer cells primes cisplatin insensitivity.

Chen H, Lan X, Liu M, Zhou B, Wang B, Chen P.

Cell Biol Int. 2013 May;37(5):478-84. doi: 10.1002/cbin.10067. Epub 2013 Mar 13.

PMID:
23584798
9.

Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer.

Nomura A, Majumder K, Giri B, Dauer P, Dudeja V, Roy S, Banerjee S, Saluja AK.

Lab Invest. 2016 Dec;96(12):1268-1278. doi: 10.1038/labinvest.2016.109. Epub 2016 Oct 24.

10.

Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.

Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.

J Exp Clin Cancer Res. 2013 Sep 5;32:62. doi: 10.1186/1756-9966-32-62.

11.

Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.

Zhang H, Meng F, Wu S, Kreike B, Sethi S, Chen W, Miller FR, Wu G.

Cancer Res. 2011 Jul 15;71(14):4846-56. doi: 10.1158/0008-5472.CAN-11-0414. Epub 2011 Jul 12.

12.

Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.

Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, Li R, Zhao QD, Yang Y, Lu ZH, Wei LX.

Cancer Lett. 2014 Oct 1;352(2):160-8. doi: 10.1016/j.canlet.2014.05.008. Epub 2014 Jun 2.

PMID:
24892648
13.

JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.

Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, Zhao J, Zhang HT.

Int J Oncol. 2014 May;44(5):1643-51. doi: 10.3892/ijo.2014.2310. Epub 2014 Feb 21.

PMID:
24573038
14.

Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.

Song R, Song H, Liang Y, Yin D, Zhang H, Zheng T, Wang J, Lu Z, Song X, Pei T, Qin Y, Li Y, Xie C, Sun B, Shi H, Li S, Meng X, Yang G, Pan S, Zhu J, Qi S, Jiang H, Zhang Z, Liu L.

Hepatology. 2014 Nov;60(5):1659-73. doi: 10.1002/hep.27312. Epub 2014 Oct 2.

PMID:
25042864
15.

Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.

Mongre RK, Sodhi SS, Sharma N, Ghosh M, Kim JH, Kim N, Park YH, Shin YG, Kim SJ, Jiao ZJ, Huynh do L, Jeong DK.

Int J Oncol. 2016 Jan;48(1):84-98. doi: 10.3892/ijo.2015.3245. Epub 2015 Nov 13.

16.

Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells.

Hong SK, Park JR, Kwon OS, Kim KT, Bae GY, Cha HJ.

Cancer Lett. 2016 Jul 1;376(2):339-46. doi: 10.1016/j.canlet.2016.04.012. Epub 2016 Apr 13.

PMID:
27085460
17.

Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.

Tian B, Li X, Kalita M, Widen SG, Yang J, Bhavnani SK, Dang B, Kudlicki A, Sinha M, Kong F, Wood TG, Luxon BA, Brasier AR.

BMC Genomics. 2015 Jul 18;16:529. doi: 10.1186/s12864-015-1707-x.

18.

Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.

Richards EJ, Zhang G, Li ZP, Permuth-Wey J, Challa S, Li Y, Kong W, Dan S, Bui MM, Coppola D, Mao WM, Sellers TA, Cheng JQ.

J Biol Chem. 2015 Mar 13;290(11):6857-67. doi: 10.1074/jbc.M114.610915. Epub 2015 Jan 20. Erratum in: J Biol Chem. 2016 Oct 21;291(43):22860.

19.

The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis.

Zhou J, You W, Sun G, Li Y, Chen B, Ai J, Jiang H.

J Pharmacol Exp Ther. 2016 Oct;359(1):54-61. doi: 10.1124/jpet.116.234799. Epub 2016 Jul 18.

PMID:
27432893
20.

Involvement of platelets in tumor cell metastasis.

Tesfamariam B.

Pharmacol Ther. 2016 Jan;157:112-9. doi: 10.1016/j.pharmthera.2015.11.005. Epub 2015 Nov 23. Review.

PMID:
26615781

Supplemental Content

Support Center